These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12091638)

  • 21. Post-transplant lymphoproliferative disorders.
    Singavi AK; Harrington AM; Fenske TS
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.
    Ville S; Imbert-Marcille BM; Coste-Burel M; Garandeau C; Meurette A; Cantarovitch D; Giral M; Hourmant M; Blancho G; Dantal J
    Transpl Int; 2018 May; 31(5):484-494. PubMed ID: 29057508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBV-associated recurrent Hodgkin's disease after renal transplantation.
    Flanagan KH; Brennan DC
    Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A; Prete A; Belotti T; Gibertoni D; Piccirilli G; Gabrielli L; Pession A; Lazzarotto T
    Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J; Einsele H; Gil L; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):383-92. PubMed ID: 19558376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus encephalitis in solid organ transplantation.
    Lau JSY; Low ZM; Abbott I; Shochet L; Kanellis J; Kitching AR; Korman TM
    New Microbiol; 2017 Jul; 40(3):212-217. PubMed ID: 28513810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type.
    Ergisi M; Ooi B; Salim O; Papalois V
    Transplant Rev (Orlando); 2024 Apr; 38(2):100837. PubMed ID: 38430887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.
    Sivaraman P; Lye WC
    Biomed Pharmacother; 2001 Sep; 55(7):366-8. PubMed ID: 11669498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
    Swinnen LJ
    J Natl Cancer Inst Monogr; 2001; (28):38-43. PubMed ID: 11158205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant lymphoproliferative disorder.
    Kalinova L; Indrakova J; Bachleda P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):251-7. PubMed ID: 20208963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
    J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
    Aris RM; Maia DM; Neuringer IP; Gott K; Kiley S; Gertis K; Handy J
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1712-7. PubMed ID: 8970360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Latest update on immunotherapy of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease].
    Hao QF; Sheng GY; Luan Z
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):795-9. PubMed ID: 24034931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells.
    Comoli P; Maccario R; Locatelli F; Valente U; Basso S; Garaventa A; Tomà P; Botti G; Melioli G; Baldanti F; Nocera A; Perfumo F; Ginevri F
    Am J Transplant; 2005 Jun; 5(6):1415-22. PubMed ID: 15888049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
    Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
    Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus infection in children with renal transplantation: A single-centre experience.
    You J; Kim M; Lee J; Han DJ; Park YS; Lee JH
    Nephrology (Carlton); 2018 Nov; 23(11):1039-1045. PubMed ID: 28869325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.